Protein Science Sheba protein
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BROWNLIE, P. D.
Right arrow Articles by WOOD, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BROWNLIE, P. D.
Right arrow Articles by WOOD, S. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Protein Science, Vol 3, Issue 10 1644-1650, Copyright © 1994 by Cold Spring Harbor Laboratory Press


INVITED PAPER, SPECIAL SECTION IN HONOR OF MAX PERUTZ

The three-dimensional structures of mutants of porphobilinogen deaminase: Toward an understanding of the structural basis of acute intermittent porphyria

P. D. BROWNLIE, R. LAMBERT, G. V. LOUIE, P. M. JORDAN, T. L. BLUNDELL, M. J. WARREN, J. B. COOPER and S. P. WOOD
Laboratory of Molecular Biology, Department of Crystallography, Birkbeck College, University of London, Malet St., London WC1E7HX, United Kingdom Present address: European Molecular Biology Laboratory, Postfach 1022.40, DW-6900 Heidelberg, Germany.

Mutations in the human gene for the enzyme porphobilinogen deaminase give rise to an inherited disease of heme biosynthesis, acute intermittent porphyria. Knowledge of the 3-dimensional structure of human porphobilinogen deaminase, based on the structure of the bacterial enzyme, allows correlation of structure with gene organization and leads to an understanding of the relationship between mutations in the gene, structural and functional changes of the enzyme, and the symptoms of the disease. Most mutations occur in exons 10 and 12, often changing amino acids in the active site. Several of these are shown to be involved in binding the primer or substrate; none modifies Asp 84, which is essential for catalytic activity.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BioinformaticsHome page
C. Deutsch and B. Krishnamoorthy
Four-Body Scoring Function for Mutagenesis
Bioinformatics, November 15, 2007; 23(22): 3009 - 3015.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
C. Solis, A. Martinez-Bermejo, T. P. Naidich, W. E. Kaufmann, K. H. Astrin, D. F. Bishop, and R. J. Desnick
Acute Intermittent Porphyria: Studies of the Severe Homozygous Dominant Disease Provides Insights Into the Neurologic Attacks in Acute Porphyrias
Arch Neurol, November 1, 2004; 61(11): 1764 - 1770.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by The Protein Society.